Winslow Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-9
| Closed | -$3K | – | 97 |
|
|
2017
Q4 | $3K | Hold |
9
| – | – | ﹤0.01% | 88 |
|
|
2017
Q3 | $4K | Sell |
9
-10
| -53% | -$4.44K | ﹤0.01% | 78 |
|
|
2017
Q2 | $9K | Sell |
19
-561,907
| -100% | -$266M | ﹤0.01% | 71 |
|
|
2017
Q1 | $218M | Sell |
561,926
-212,592
| -27% | -$82.4M | 1.04% | 54 |
|
|
2016
Q4 | $284M | Buy |
774,518
+7,498
| +1% | +$2.75M | 1.31% | 28 |
|
|
2016
Q3 | $308M | Sell |
767,020
-68,417
| -8% | -$27.5M | 1.28% | 28 |
|
|
2016
Q2 | $292M | Buy |
+835,437
| New | +$292M | 1.19% | 39 |
|
|
2016
Q1 | – | Sell |
-278,602
| Closed | -$151M | – | 151 |
|
|
2015
Q4 | $151M | Sell |
278,602
-18,449
| -6% | -$10M | 0.54% | 61 |
|
|
2015
Q3 | $138M | Buy |
+297,051
| New | +$138M | 0.5% | 62 |
|
|
2014
Q3 | – | Sell |
-7
| Closed | -$2K | – | 82 |
|
|
2014
Q2 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 72 |
|